PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical
Recalled February 12, 2025 · FDA recall D-0222-2025 · PAI Holdings, LLC.
Hazard
Superpotent; sodium benzoate preservative · FDA Class III
Units
4080 Bottles
Sold at
OH
Description
Superpotent; sodium benzoate preservative
Product
Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16
Manufacturer(s)
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →